Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Tenon Medical, Inc. (TNON – Research Report) yesterday. The company’s shares opened today at $0.86.
Vendetti covers the Healthcare sector, focusing on stocks such as Lucid Diagnostics, Biolase, and Nuwellis. According to TipRanks, Vendetti has an average return of -6.2% and a 32.80% success rate on recommended stocks.
Tenon Medical, Inc. has an analyst consensus of Moderate Buy, with a price target consensus of $3.00.
The company has a one-year high of $18.60 and a one-year low of $0.71. Currently, Tenon Medical, Inc. has an average volume of 253.9K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenon Medical, Inc. (TNON) Company Description:
Tenon Medical Inc is a a medical device company. It manufacturers instruments and implants for sacroiliac joint fusion surgery.
Read More on TNON:
- Tenon Medical files to sell 5.01M shares of common stock for holders
- Tenon Medical price target lowered to $3 from $5 at Benchmark
- Tenon Medical, Inc. Enhances Board with New Appointment
- Tenon Medical’s Partnership Perils: Navigating Uncharted Waters in Search of Commercial Success
- Tenon Medical appoints Kristine Jacques to board of directors
